ImportRefusal LogoImportRefusal

GUSTAVO PEREZ MAGALLON

⚠️ High Risk

FEI: 3031213717 • Zapopan • MEXICO

FEI

FEI Number

3031213717

📍

Location

Zapopan

🇲🇽

Country

MEXICO
🏢

Address

Santa Esther 409, 2da Secc, Col Santa Margarita, Zapopan, , Mexico

High Risk

FDA Import Risk Assessment

57.5
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

5
Total Refusals
3
Unique Violations
7/21/2025
Latest Refusal
10/1/2024
Earliest Refusal

Score Breakdown

Violation Severity
71.7×40%
Refusal Volume
28.8×30%
Recency
76.0×20%
Frequency
50.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

754×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

3241×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

4821×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

Refusal History

DateProductViolationsDivision
7/21/2025
61XDA08CHLORPHENIRAMINE MALEATE (ANTI-HISTAMINIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/21/2025
61XDA08CHLORPHENIRAMINE MALEATE (ANTI-HISTAMINIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/20/2025
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/20/2025
60LDY01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/1/2024
41BYY99FOODS WITH SUPPLEMENTAL NUTRIENTS ADDED, WITH OR WITHOUT ARTIFICAL SWEETNERS
324NO ENGLISH
482NUTRIT LBL
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is GUSTAVO PEREZ MAGALLON's FDA import refusal history?

GUSTAVO PEREZ MAGALLON (FEI: 3031213717) has 5 FDA import refusal record(s) in our database, spanning from 10/1/2024 to 7/21/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GUSTAVO PEREZ MAGALLON's FEI number is 3031213717.

What types of violations has GUSTAVO PEREZ MAGALLON received?

GUSTAVO PEREZ MAGALLON has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about GUSTAVO PEREZ MAGALLON come from?

All FDA import refusal data for GUSTAVO PEREZ MAGALLON is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.